PETROLEO BRASILEIRO-SPON ADR (PBR)       14.37  -0.14 (-0.96%)

14.37  -0.14 (-0.96%)

US71654V4086 - ADR


Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to PBR. PBR was compared to 378 industry peers in the Oil, Gas & Consumable Fuels industry. While PBR has a great profitability rating, there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on PBR.




Profitability

Profitability Rating

8

PBR's Return On Assets of 16.08% is amongst the best of the industry. PBR does better than the industry average Return On Assets of 5.47%.
PBR's Return On Equity of 39.35% is amongst the best of the industry. PBR does better than the industry average Return On Equity of 24.13%.

PBR's Profit Margin of 28.42% is amongst the best of the industry. PBR does better than the industry average Profit Margin of 17.26%.
The Piotroski-F score of PBR is 8.00. This is a very strong score and indicates great health and profitability for PBR.
VS Industry

ROA (16.08%) VS Industry: 79% outperformed.

-63,651.82
767.41

ROE (39.35%) VS Industry: 73% outperformed.

0.26
5,310.48

Profit Margin (28.42%) VS Industry: 63% outperformed.

-57,028.57
296.15

Valuation

Valuation Rating

9

The Price/Earnings Ratio is 3.90, which indicates a rather cheap valuation of PBR.
PBR's Price/Earning Ratio is rather cheap when compared to the industry average which is at 7.86. PBR is also cheaper than 84% of the companies in the same industry.
With a Forward Price/Earnings Ratio of 3.58, the valuation of PBR can be described as cheap.
PBR's low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

Compared to an average industry price book ratio of 1.81, PBR is valued rather cheaply
Compared to an average Enterprise Value to EBITDA ratio of 4.74, PBR is valued rather cheaply. On top of this, PBR has a better ratio than 90% of the companies listed in the same industry.
When comparing the current price to the book value of PBR, we can conclude it is valued correctly. It is trading at 1.23 times its book value.
VS Industry

Price/Earnings (3.9) VS Industry: 84% outperformed.

1,099.00
0.04

Price/Book (1.23) VS Industry: 72% outperformed.

2,640.11
0.02

Enterprise Value/ EBITDA (2.03) VS Industry: 90% outperformed.

2,584.37
0.04

Growth

Growth Rating

5

PBR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 74.68%, which is quite impressive.
Measured over the past 5 years, PBR shows a very strong growth in Earnings Per Share. The EPS has been growing by 45.36% on average per year.
PBR shows a strong growth in Revenue. In the last year, the Revenue has grown by 65.91%.
PBR is expected to show a decrease in Earnings Per Share. In the coming 5 years, the EPS will decrease by -4.53% yearly.

The Revenue has been growing slightly by 9.88% on average over the past 5 years.
Based on estimates for the next 5 years, PBR will show a small growth in Revenue. The Revenue will grow by 0.28% on average per year.
The EPS growth is decreasing: in the next 5 years the growth will be less than in the last years.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS45.36% 37.77% 74.68% 112.54% 30.18% 9.63% -4.53%
Revenue9.88% 13.42% 65.91% 45.38% 16.52% 7.2% 0.28%

Health

Health Rating

6

The Piotroski-F score of PBR is 8.00. This is a very strong score and indicates great health and profitability for PBR.
PBR has a Current Ratio of 1.31. This is a normal value and indicates that PBR is financially healthy and should not expect problems in meeting its short term obligations.
PBR has a Current Ratio comparable to the industry average, which is at 1.16.
PBR has a Quick Ratio of 1.02. This is a normal value and indicates that PBR is financially healthy and should not expect problems in meeting its short term obligations.

The Quick Ratio is in line with the industry averages, which is at 1.02.
An Altman-Z score of 2.25 indicates that PBR is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score is in line with the industry averages, which is at 1.95.
When comparing the Debt to Equity Ratio of PBR to the average industry Debt to Equity Ratio of 0.29, PBR required more debt to finance its operations than its industry peers.
VS Industry

Debt/Equity (0.56) VS Industry: 34% outperformed.

150.19
0.00

Quick Ratio (1.02) VS Industry: 50% outperformed.

0.00
295.99

Current Ratio (1.31) VS Industry: 57% outperformed.

0.00
295.99

Altman-Z (2.25) VS Industry: 54% outperformed.

-110,323.97
1,587.26

Dividend

Dividend Rating

8

With a Yearly Dividend Yield of 54.35%, PBR is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.18, PBR pays a better dividend. On top of this PBR pays more dividend than 99% of the companies listed in the same industry.
PBR's Dividend Yield is rather good when compared to the S&P500 average which is at 2.63.
The dividend of PBR is nicely growing with an annual growth rate of 83.17%!

PBR has been paying a dividend for at least 10 years, so it has a reliable track record.
PBR's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
76.70% of the earnings are spent on dividend by PBR. This is not a sustainable payout ratio.
VS Industry

Dividend Yield (54.35%) VS Industry: 99% outperformed.

0.35
54.35
PBR Daily chart

PETROLEO BRASILEIRO-SPON ADR14.37

NYSE:PBR (10/7/2022, 1:34:09 PM)-0.14 (-0.96%)

Chartmill FA Rating
GICS Sector Energy
GICS IndustryGroup Energy
GICS Industry Oil, Gas & Consumable Fuels
Earnings (Last) 07-29 2022-07-29/bmo Earnings (Next) 10-27 2022-10-27/bmo
Ins Owners N/A Inst Owners 12.06%
Market Cap 93.72B Analysts 80
Valuation
PE 3.9 Fwd PE 3.58
PEG (NY) 0.03 PEG (5Y) 0.09
P/S 0.89 P/B 1.23
EV/EBITDA 2.03
Dividend
Dividend Yield 54.35% Dividend Growth 83.17%
DP 76.7% Ex-Date 08-12 2022-08-12 (3.7248596000000003)
Growth
EPS 1Y 74.68% EPS 3Y 37.77%
EPS 5Y 45.36% EPS growth Q2Q 10.58%
EPS Next Y 112.54% EPS Next 2Y 30.18%
EPS Next 3Y 9.63% EPS Next 5Y -4.53%
Revenue growth 1Y 65.91% Revenue growth 3Y 13.42%
Revenue growth 5Y 9.88% Revenue growth Q2Q 54.42%
Revenue Next Year 45.38% Revenue Next 2Y 16.52%
Revenue Next 3Y 7.2% Revenue Next 5Y 0.28%
Health
Current Ratio 1.31 Quick Ratio 1.02
Altman-Z 2.25 F-Score 8
Debt/Equity 0.56 WACC 15.63%
ROIC/WACC 1.31
Profitability
ROA 16.08% ROE 39.35%
ROIC 20.54% ROICg 20.12%
PM 28.42% OM 41.7%
Asset Turnover 0.57

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA